Entero Healthcare Solutions Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 105.64 | 98.18 | 128.66 |
| Operating Expense | 93.06 | 131.32 | 111.63 |
| Net Profit | 6.96 | -27.81 | 10.78 |
| Net Profit Margin | 6.59 | -28.33 | 8.38 |
| Earning Per Share | 1.60 | -6.39 | 2.48 |
| EBIDTA | 10.37 | -31.72 | 13.96 |
| Effective Tax Rate | TBA | 19.37 | 3.64 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 105.64 |
| Operating Expense | 93.06 |
| Net Profit | 6.96 |
| Net Profit Margin | 6.59 |
| Earning Per Share | 1.60 |
| EBIDTA | 10.37 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 408.67 | 318.16 | 177.69 |
| Operating Expenses Annual | 439.02 | 352.66 | 221.61 |
| Operating Profit Annual | 36.94 | 55.43 | 8.65 |
| Interest Annual | 1.52 | 22.32 | 11.30 |
| Depreciation | 8.13 | 8.35 | 9.18 |
| Net Profit Annual | 19.18 | 38.44 | -12.46 |
| Tax Annual | 7.60 | -14.08 | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 408.67 |
| Operating Expenses Annual | 439.02 |
| Operating Profit Annual | 36.94 |
| Interest Annual | 1.52 |
| Depreciation | 8.13 |
| Net Profit Annual | 19.18 |
| Tax Annual | 7.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 93.34 | 6.12 | 30.20 |
| Cash Flow from Operations | -109.02 | -75.65 | -56.91 |
| Cash Flow from Investing | 207.75 | -762.69 | -58.29 |
| Cash Flow from Financing | -40.89 | 925.56 | 91.11 |
| Cash Flow at the End | 151.18 | 93.34 | 6.12 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 93.34 |
| Cash Flow from Operations | -109.02 |
| Cash Flow from Investing | 207.75 |
| Cash Flow from Financing | -40.89 |
| Cash Flow at the End | 151.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 20.50 | 17.42 | 4.87 |
| PBIT Margin (%) | 18.38 | 14.67 | -0.65 |
| PBT Margin (%) | 6.28 | 14.01 | -0.59 |
| Net PROFIT Margin (%) | 4.69 | 12.08 | -7.01 |
| Return On Networth / Equity (%) | 3.15 | 4.83 | TBA |
| Return On Networth /Employed (%) | 4.43 | 3.91 | TBA |
| Return On Assets (%) | 1.17 | 3.26 | -1.89 |
| Total Debt / Equity (X) | 0.01 | 0.06 | 0.15 |
| Asset Turnover Ratio (%) | 0.25 | 0.27 | 0.27 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 20.50 |
| PBIT Margin (%) | 18.38 |
| PBT Margin (%) | 6.28 |
| Net PROFIT Margin (%) | 4.69 |
| Return On Networth / Equity (%) | 3.15 |
| Return On Networth /Employed (%) | 4.43 |
| Return On Assets (%) | 1.17 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 28.55 | 34.44 | 40.65 |
| Total Current Assets Annual | 809.46 | 1,660.99 | 673.00 |
| Non Current Assets Annual | 994.07 | 107.60 | 90.56 |
| Total Shareholders Funds Annual | 1,650.38 | 1,626.41 | 583.73 |
| Total Assets Annual | 1,803.53 | 1,768.58 | 763.57 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 28.55 |
| Total Current Assets Annual | 809.46 |
| Non Current Assets Annual | 994.07 |
| Total Shareholders Funds Annual | 1,650.38 |
| Total Assets Annual | 1,803.53 |
EPS (INR)
Expected
6.39
Reported
6.39
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.17%
Sep 2024
EPS beaten by 0.00%
